These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2385611)

  • 1. Percutaneous BCG perfusion of the upper urinary tract for carcinoma in situ.
    Studer UE; Casanova G; Kraft R; Zingg EJ
    Prog Clin Biol Res; 1990; 350():81-6. PubMed ID: 2385611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Percutaneous Bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ].
    Yamashita S; Yogi Y; Taniguchi K; Morimitsu H; Suzu H; Kanetake H; Saito Y; Kubota S
    Hinyokika Kiyo; 1992 Oct; 38(10):1095-9. PubMed ID: 1481770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous BCG perfusion of the upper urinary tract for carcinoma in situ.
    Studer UE; Casanova G; Kraft R; Zingg EJ
    Prog Clin Biol Res; 1989; 310():207-12. PubMed ID: 2771994
    [No Abstract]   [Full Text] [Related]  

  • 4. When is a cystectomy necessary in carcinoma in situ?
    Herr HW
    Prog Clin Biol Res; 1989; 303():511-5. PubMed ID: 2780659
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravesical Bacillus Calmette Guerin therapy in patients with superficial bladder tumor.
    Steg A; Belas M; Leleu C; Boccon-Gibod L
    Prog Clin Biol Res; 1989; 303():375-81. PubMed ID: 2780654
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of flat carcinoma in situ of the bladder.
    Whitmore WF
    Prog Clin Biol Res; 1984; 162B():219-24. PubMed ID: 6504897
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of carcinoma in situ of the urinary bladder with BCG].
    Schnyder von Wartensee M; Ackermann D; Studer UE; Zingg EJ
    Helv Chir Acta; 1989 Aug; 56(3):351-4. PubMed ID: 2807965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravesical immunotherapy of in situ carcinoma of the urinary bladder using Bacillus Calmette-Guerin (BCG)].
    Jakse G
    Wien Klin Wochenschr; 1987 Feb; 99(4):114-8. PubMed ID: 3577186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observation of 8 cases of carcinoma in situ of the urinary bladder].
    Murase T; Ito H; Ohishi M; Takashi M
    Hinyokika Kiyo; 1989 Apr; 35(4):583-5. PubMed ID: 2735263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma].
    Mori H; Miyaji B; Takahashi M; Matsuda K; Tsuka H; Wada O; Aoki Y; Akino H; Muranaka K; Kanamaru H; Okada K; Imamura Y
    Hinyokika Kiyo; 1996 Apr; 42(4):257-61. PubMed ID: 8693956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Topical BCG therapy of in situ cancer of the urinary bladder].
    Mack D; Jakse G
    Urologe A; 1987 Jan; 26(1):22-5. PubMed ID: 3576860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG in the management of superficial bladder cancer.
    Guinan P; Richardson C; Hanna M; Rubenstein M
    Prog Clin Biol Res; 1989; 303():447-53. PubMed ID: 2675002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of superficial bladder cancer.
    Grossman HB
    Compr Ther; 1995 May; 21(5):245-8. PubMed ID: 7621655
    [No Abstract]   [Full Text] [Related]  

  • 16. [The diagnosis and treatment for carcinoma in situ of the bilateral upper urinary tracts after total cystectomy and ileal conduit by intentionally inducing hydronephrosis].
    Saito J; Kato T; Kakuta Y; Tanaka M; Yazawa K; Hosomi M; Ito K
    Hinyokika Kiyo; 2006 Jul; 52(7):573-5. PubMed ID: 16910594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
    Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG therapy of superficial bladder tumors.
    Herr HW
    Prog Clin Biol Res; 1989; 303():369-74. PubMed ID: 2674999
    [No Abstract]   [Full Text] [Related]  

  • 19. [The influence over the long-term prognosis of BCG therapy and the surgical treatment in superficial bladder cancer treatment].
    Higashi S; Matsui Y; Takahashi T; Nishiyama H; Ito N; Yamamoto S; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2005 Aug; 51(8):529-31. PubMed ID: 16164268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of superficial tumors and carcinomas in situ of the bladder by intravesical BCG therapy].
    Steg A; Leleu C; Boccon-Gibod L; Debré B
    Ann Urol (Paris); 1986; 20(1):26-32. PubMed ID: 3707074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.